Company Focus

Novartis

Latest Novartis News



Insights

Company Spotlight

Latest News & Features of interest to Novartis

Latest In Brief for Novartis

Biotechnology
Sweden-based BioArctic saw its fall 7.5% to 139.90 kronor on Friday, after its announced that its partner, Japan’s Eisa, has updated its revenue outlook for the Alzheimer’s treatment Leqembi (lecanemab) for the 2024 fiscal year (FY), which runs from April 2024 through March 2025.   11 November 2024

Latest Ones To Watch News

Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS).   12 November 2024

More in M&A >


Ones to Watch Companies

Reset all filters
Refine Search